Vermillion (VRML) Names Industry Vet Thomas McLain as CEO
Tweet
Share
E-mailGet Alerts VRML Hot Sheet
Join SI Premium – FREE
Vermillion, Inc. (NASDAQ: VRML) has appointed Thomas McLain as president and chief executive officer effective March 18, 2013. He succeeds Bruce Huebner, the company's interim chief executive officer, who will remain a director of the company and assist in the transition.
McLain brings to Vermillion more than 20 years of experience in executive management and corporate governance for both public and privately held companies, with a strong record of turning companies into leading players in the medical diagnostic and biotechnology industry.
McLain brings to Vermillion more than 20 years of experience in executive management and corporate governance for both public and privately held companies, with a strong record of turning companies into leading players in the medical diagnostic and biotechnology industry.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ispire Technology names Steven Przybyla president, adds to CLO role
- AE Fuels names Jason Tong as new CFO after prior executive's exit
- Cable One names Heather McCallion as chief operating officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
